Device manufacturer, as written on reports
Roche Diagnostics: medical device reports filed with FDA
130,841 reports name it as the manufacturer of the device involved, 1997–2026.
- 130,841
- reports naming it as manufacturer
- 0.5% of all MAUDE reports
- 5,702
- reports, 12 months to August 2026
- 3,901 in the 12 months before
- 93.3%
- classified as malfunction
- 62.3% across all reports
- 0.1%
- classified as death, as reported
- 0.9% across all reports
130,841 medical device reports received by FDA give Roche Diagnostics as the manufacturer of the device involved, 0.5% of the MAUDE database, from February 1997 to August 2026. Manufacturer names are as written on the report; subsidiaries and spelling variants may appear as separate names.
5,702 reports arrived in the 12 months to August 2026, up 46% from 3,901 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (93.3%), injury (6.5%) and death (0.1%). Manufacturers are required to report events they learn of, so a large manufacturer with many products in use files many reports. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands named most often
| Brand | Device type | Reports | Latest 12 months | Classified as death |
|---|---|---|---|---|
| Coaguchek Xs System | Test, time, prothrombin | 14,927 | 2 | 0.1% |
| Accu-Chek Comfort Curve Test Strips | Glucose dehydrogenase, glucose | 13,040 | 0 | 0% |
| Accu-Chek Aviva Test Strips | Glucose dehydrogenase, glucose | 9,240 | 0 | 0% |
| Accu-Chek Compact Test Drum | Glucose dehydrogenase, glucose | 7,051 | 0 | 0% |
| Accu-Chek Multiclix | Single use only blood lancet with an integral sharps injury prevention feature | 5,303 | 0 | 0% |
| Accu-Chek Comfort Curve | Hexokinase, glucose | 3,959 | 0 | 0.6% |
| Accu-Chek Aviva Plus Test Strips | Glucose dehydrogenase, glucose | 2,952 | 0 | 0% |
| Accu-Chek Mobile Test Strips | Glucose dehydrogenase, glucose | 2,919 | 0 | 0% |
| cobas 6000 c501 module | Analyzer, chemistry (photometric, discrete), for clinical use | 2,714 | 194 | 0.1% |
| Coaguchek S System | System, multipurpose for in vitro coagulation studies | 2,663 | 0 | 0% |
| Accu-Chek Spirit Combo | Pump, infusion, insulin | 2,235 | 0 | 0.1% |
| COBAS 6000 C (501) Module | Analyzer, chemistry (photometric, discrete), for clinical use | 2,161 | 129 | 0% |
| Softclix Lancet Device | Single use only blood lancet with an integral sharps injury prevention feature | 1,920 | 80 | 0% |
| cobas c 503 analytical unit | Analyzer, chemistry (photometric, discrete), for clinical use | 1,415 | 541 | 0% |
| Cobas 8000 C 702 Module | Analyzer, chemistry (photometric, discrete), for clinical use | 1,283 | 0 | 0% |
| Accu-Chek Advantage | System, test, blood glucose, over the counter | 1,171 | 0 | 0.5% |
| Cobas E 411 Immunoassay Analyzer | Analyzer, chemistry (photometric, discrete), for clinical use | 1,145 | 0 | 0.1% |
| cobas Integra 400 plus | Analyzer, chemistry (photometric, discrete), for clinical use | 1,088 | 52 | 0.1% |
| Accu-Chek Aviva Combo | System, test, blood glucose, over the counter | 1,064 | 2 | 0% |
| Softclix Plus Lancet Device | Single use only blood lancet with an integral sharps injury prevention feature | 1,039 | 0 | 0% |
| Accu-Chek Active Test Strips | Glucose dehydrogenase, glucose | 1,025 | 0 | 0% |
| cobas 8000 e 801 Module | Analyzer, chemistry (photometric, discrete), for clinical use | 1,008 | 52 | 0% |
| Accu-Chek Performa Test Strips | System, test, blood glucose, over the counter | 980 | 1 | 0% |
| Coaguchek Pt Test Strips | System, multipurpose for in vitro coagulation studies | 920 | 0 | 0.1% |
| cobas 6000 e601 module | Analyzer, chemistry (photometric, discrete), for clinical use | 894 | 85 | 0% |
| Cobas Integra 800 | Analyzer, chemistry (photometric, discrete), for clinical use | 882 | 0 | 0% |
| Cobas 6000 E 601 Module | Analyzer, chemistry (photometric, discrete), for clinical use | 870 | 0 | 0% |
| cobas pro ISE analytical unit | Analyzer, chemistry (photometric, discrete), for clinical use | 864 | 319 | 0% |
| Accu-Chek Inform Meter | System, test, blood glucose, over the counter | 795 | 0 | 0.1% |
| Analytical P Module | Analyzer, chemistry (photometric, discrete), for clinical use | 743 | 0 | 0% |
Brands with a page on this site, ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Device types
| Product code | Device type | Reports | Share |
|---|---|---|---|
| LFR | Glucose dehydrogenase, glucose | 39,628 | 30.3% |
| JJE | Analyzer, chemistry (photometric, discrete), for clinical use | 27,179 | 20.8% |
| GJS | Test, time, prothrombin | 16,389 | 12.5% |
| FMK | Single use only blood lancet with an integral sharps injury prevention feature | 9,631 | 7.4% |
| NBW | System, test, blood glucose, over the counter | 9,450 | 7.2% |
| CFR | Hexokinase, glucose | 4,118 | 3.1% |
| JPA | System, multipurpose for in vitro coagulation studies | 4,030 | 3.1% |
| LZG | Pump, infusion, insulin | 3,045 | 2.3% |
| MMI | Immunoassay method, troponin subunit | 1,677 | 1.3% |
| CDP | Radioimmunoassay, total triiodothyronine | 1,182 | 0.9% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type
Grey bar: all 26,136,888 MAUDE reports. Event type is the filer's classification and is not verified by FDA.
Questions about Roche Diagnostics reports
How many FDA device reports name Roche Diagnostics as manufacturer?
130,841 reports through August 2026, 5,702 of them in the latest 12 months.
Which of its brands appear most often?
Coaguchek Xs System (14,927), Accu-Chek Comfort Curve Test Strips (13,040), Accu-Chek Aviva Test Strips (9,240), Accu-Chek Compact Test Drum (7,051) and Accu-Chek Multiclix (5,303).
Which device types does it report on?
glucose dehydrogenase, glucose (30.3%), analyzer, chemistry (photometric, discrete), for clinical use (20.8%), test, time, prothrombin (12.5%) and single use only blood lancet with an integral sharps injury prevention feature (7.4%).
Does a high count say something about the manufacturer?
Not by itself. Manufacturers must file a report for every event they become aware of, so report volume follows the number of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. Manufacturer names are pooled after company suffixes (Inc., LLC, GmbH and similar) are dropped; names that read as a person rather than an organisation are never published. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.